Advertisement
Home Tags Diabetes: Type II

Tag: Diabetes: Type II

In patients with type 2 diabetes

Retinal Sensitivity Linked to Cognitive Status in T2DM

Retinal sensitivity assessed by microperimetry is correlated with neurodegeneration parameters
Incretin treatment appears to improve non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes and non-obstructive coronary artery stenosis

Incretin Tied to Better Outcomes in NOCS-Diabetes

Prognosis for T2DM patients with NSTEMI, coronary artery stenosis improves with incretin
Management of type 2 diabetes should include shared decision making

New Clinical Practice Guideline for Management of T2DM

Individualized management should include education, glycemic management plans, target HbA1c
For populations at high-risk for diabetes

Statins May Raise Odds of T2DM in Those at High Risk

In any Diabetes Prevention Program treatment group, statin use tied to increased diabetes risk
The sodium glucose co-transporter 2 inhibitor tofogliflozin is effective for reducing fasting plasma glucose and body weight

Tofogliflozin Most Effective With High Baseline Insulin

These patients have largest improvements in fasting plasma glucose level, insulin secretion index
Among patients with type 2 diabetes and atherosclerotic cardiovascular disease

Sudden Death Most Common CV Death in T2DM/ASCVD

27 percent of CV deaths in diabetes patients with atherosclerotic CVD are categorized as sudden death
Oral semaglutide is associated with better glycemic control than placebo among type 2 diabetes patients with insufficient glycemic control

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Phase 3 studies next to assess longer-term/clinical outcomes, safety
Adding a sulfonylurea or metformin to insulin is associated with approximately a 1 percent reduction in hemoglobin A1c

Clinical Evidence Synopsis Published for T2DM

Adding sulfonylurea or metformin to insulin decreases HbA1c about 1%
Primary care referral along with a commercial weight management provider can deliver an effective diabetes prevention program

Commercial Weight Management Program May Help Prevent T2D

Primary care referral to Weight Watchers is associated with weight loss, HbA1c reduction
Oral semaglutide is associated with better glycemic control than placebo among type 2 diabetes patients with insufficient glycemic control

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Phase 3 studies next to assess longer-term/clinical outcomes, safety